Boston Historical Income Statement

BSX Stock  USD 68.49  0.13  0.19%   
Historical analysis of Boston Scientific income statement accounts such as Interest Expense of 193.9 M, Selling General Administrative of 5.2 B or Total Revenue of 15 B can show how well Boston Scientific Corp performed in making a profits. Evaluating Boston Scientific income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Boston Scientific's future profits or losses.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Boston Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boston Scientific Corp is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

About Boston Income Statement Analysis

Boston Scientific Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Boston Scientific shareholders. The income statement also shows Boston investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Boston Scientific Income Statement Chart

Boston Scientific Corp Income Statement is one of the three primary financial statements used for reporting Boston's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Boston Scientific Corp revenue and expense. Boston Scientific Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024.

Total Revenue

Total revenue comprises all receipts Boston Scientific Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Boston Scientific Corp minus its cost of goods sold. It is profit before Boston Scientific operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Boston Scientific Corp. It is also known as Boston Scientific overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Boston Scientific's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit8.1B8.7B9.9B10.4B
Total Revenue11.9B12.7B14.2B15.0B

Boston Scientific income statement Correlations

0.430.930.940.930.940.60.830.920.940.930.550.220.330.20.73-0.670.36-0.280.060.36-0.2-0.450.510.81
0.430.590.560.540.580.20.330.380.590.570.06-0.150.31-0.430.790.20.44-0.02-0.1-0.370.19-0.770.090.49
0.930.591.00.991.00.590.880.940.981.00.510.150.43-0.010.87-0.540.5-0.230.020.16-0.3-0.470.440.78
0.940.561.01.00.990.590.910.960.990.990.520.150.420.010.85-0.580.49-0.220.00.18-0.32-0.450.450.78
0.930.540.991.00.990.610.910.960.970.990.540.180.45-0.010.84-0.590.51-0.25-0.040.17-0.36-0.440.440.77
0.940.581.00.990.990.560.870.930.991.00.480.120.390.010.86-0.560.46-0.190.050.18-0.28-0.470.470.8
0.60.20.590.590.610.560.640.650.540.570.980.850.81-0.010.41-0.410.79-0.89-0.010.12-0.34-0.370.340.63
0.830.330.880.910.910.870.640.980.880.850.620.250.460.090.71-0.640.5-0.28-0.020.22-0.45-0.230.360.65
0.920.380.940.960.960.930.650.980.940.920.620.250.430.130.75-0.680.47-0.290.010.28-0.38-0.320.430.74
0.940.590.980.990.970.990.540.880.940.970.450.070.340.050.86-0.550.41-0.150.10.2-0.21-0.470.460.8
0.930.571.00.990.991.00.570.850.920.970.490.140.41-0.020.85-0.560.48-0.220.020.17-0.32-0.470.470.79
0.550.060.510.520.540.480.980.620.620.450.490.910.790.060.31-0.440.75-0.91-0.080.18-0.4-0.230.290.51
0.22-0.150.150.150.180.120.850.250.250.070.140.910.710.06-0.01-0.230.65-0.97-0.090.12-0.3-0.090.170.22
0.330.310.430.420.450.390.810.460.430.340.410.790.71-0.570.31-0.240.99-0.79-0.39-0.46-0.46-0.470.350.53
0.2-0.43-0.010.01-0.010.01-0.010.090.130.05-0.020.060.06-0.57-0.1-0.21-0.590.060.520.980.210.45-0.17-0.18
0.730.790.870.850.840.860.410.710.750.860.850.31-0.010.31-0.1-0.110.43-0.090.070.03-0.17-0.510.330.6
-0.670.2-0.54-0.58-0.59-0.56-0.41-0.64-0.68-0.55-0.56-0.44-0.23-0.24-0.21-0.11-0.190.210.11-0.320.42-0.08-0.55-0.53
0.360.440.50.490.510.460.790.50.470.410.480.750.650.99-0.590.43-0.19-0.74-0.37-0.47-0.46-0.510.330.53
-0.28-0.02-0.23-0.22-0.25-0.19-0.89-0.28-0.29-0.15-0.22-0.91-0.97-0.790.06-0.090.21-0.740.13-0.020.310.25-0.22-0.34
0.06-0.10.020.0-0.040.05-0.01-0.020.010.10.02-0.08-0.09-0.390.520.070.11-0.370.130.50.410.10.010.07
0.36-0.370.160.180.170.180.120.220.280.20.170.180.12-0.460.980.03-0.32-0.47-0.020.50.10.38-0.06-0.03
-0.20.19-0.3-0.32-0.36-0.28-0.34-0.45-0.38-0.21-0.32-0.4-0.3-0.460.21-0.170.42-0.460.310.410.1-0.24-0.41-0.08
-0.45-0.77-0.47-0.45-0.44-0.47-0.37-0.23-0.32-0.47-0.47-0.23-0.09-0.470.45-0.51-0.08-0.510.250.10.38-0.24-0.16-0.72
0.510.090.440.450.440.470.340.360.430.460.470.290.170.35-0.170.33-0.550.33-0.220.01-0.06-0.41-0.160.58
0.810.490.780.780.770.80.630.650.740.80.790.510.220.53-0.180.6-0.530.53-0.340.07-0.03-0.08-0.720.58
Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization564M789M741M1.2B1.2B1.3B
Interest Expense473M361M341M470M265M193.9M
Selling General Administrative3.9B3.8B4.4B4.5B5.0B5.2B
Total Revenue10.7B9.9B11.9B12.7B14.2B15.0B
Gross Profit7.6B6.4B8.1B8.7B9.9B10.4B
Other Operating Expenses9.0B9.2B10.1B10.6B11.8B12.4B
Operating Income1.5B1.0B2.0B1.6B2.3B2.5B
Ebit1.5B1.0B2.0B1.6B2.4B2.5B
Ebitda2.1B1.8B2.8B2.8B3.6B3.8B
Cost Of Revenue3.2B3.5B3.8B4.0B4.3B4.6B
Total Operating Expenses5.8B5.7B6.3B6.6B7.5B7.9B
Income Before Tax687M(138M)1.1B1.1B2.0B2.1B
Total Other Income Expense Net(831M)(1.2B)(967M)(508M)(188M)(197.4M)
Net Income4.7B(140M)1.0B698M1.6B1.7B
Income Tax Expense(4.0B)2M36M443M393M412.7M
Research Development1.2B1.1B1.2B1.3B1.4B884.9M
Net Income Applicable To Common Shares4.7B(115M)986M642M738.3M775.2M
Net Income From Continuing Ops4.7B(81M)1.0B698M1.2B1.3B
Non Recurring323M908M889M376M338.4M321.5M
Non Operating Income Net Other(358M)362M218M(38M)(43.7M)(41.5M)
Tax Provision(4.0B)2M36M443M647M679.4M
Interest Income30M361M341M470M22M20.9M
Net Interest Income(443M)(361M)(341M)(470M)(254M)(266.7M)
Reconciled Depreciation1.0B1.1B741M803M1.2B1.0B

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boston Stock

  0.62COO Cooper Companies Financial Report 6th of June 2024 PairCorr

Moving against Boston Stock

  0.89PHG Koninklijke Philips Financial Report 22nd of April 2024 PairCorr
  0.87PIIIW P3 Health PartnersPairCorr
  0.82MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.81MASS 908 Devices Financial Report 14th of May 2024 PairCorr
  0.77NEOG Neogen Report 4th of April 2024 PairCorr
The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.
The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.856
Earnings Share
1.07
Revenue Per Share
9.8
Quarterly Revenue Growth
0.149
Return On Assets
0.0447
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.